Study on Hepatocyte-targeted Liposomes

[1]

Feng Zhao, Rui Wang, Hongxiong Zhang, Taixiang Gao, Nan Wang. Pharmacodynamics of Yuebi Jiazhu Decoction on renal protection of adriamycin nephropathy rats [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(9): 711-717.

[2]

Yajie Liu, Yu Wang, Jiajia Li, Xiaoqing Xu, Xinru Li. Preparation and evaluation of doxorubicin-luminespib co-loaded multivesicular liposomes [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(9): 736-742.

[3]

Xuan Luo, Qing Du, Haiyan Zhao, Wenhai Fan, Xin Gao, Xia Gao. Extractum trametes robiniophila murr protects murine podocyte via actin cytoskeleton stabilization [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(3): 230-238.

[4]

Yitian Du, Lu Zhang, Yin Zhan, Xinyu Chai, Kaisen Li, Xianrong Qi. Interferon-liposomes prepared to make macroglia maintain M1 phenotype [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(7): 476-483.

[5]

Bo Deng, Wei Cui, Shuang Ma, Xiaona Liu, Zhan Zhang, Baiyi Yan, Kun Chen, Ying Xie. Molecular basis for rational construction of RVGP modified liposomal delivery system targeting to brain [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(7): 484-501.

[6]

[7]

Wenxi Zhang, Guanghua Peng, Maoyuan Song, Jiaxing Wang, Mengya Yin, Jiajia Li, Yajie Liu, Yuanyuan Zhang, Xinru Li. Preparation and evaluation of liposomal clarithromycin with antimicrobial effect [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(6): 408-414.

[8]

Maoyuan Song, Yuanyuan Zhang, Wenxi Zhang, Guanghua Peng, Jiaxing Wang, Mengya Yin, Jiajia Li, Yajie Liu, Xinru Li. Preparation, characterization and evaluation of multi-component-loaded liposomes containing Tat-TOS, phospholipase D inhibitor and doxorubicin [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 332-341.

[9]

[10]

Jingying Zhang, Qian Luo, Jiarui Xu, Jing Bai, Lei Liu, Limin Mu, Yan Yan, Wanliang Lu. A derivatization method to improve the assay of salinomycin sodium and its application in the liposomal formulation [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(2): 75-81.

[11]

Jiongxi Lei, Shuangchen Cong, Maoyuan Song, Wenxi Zhang, Guanghua Peng, Yuanyuan Zhang, Mengya Yin, Jiaxing Wang, Jiajia Li, Xinru Li. Preparation, characterization and evaluation of liposomal doxorubicin and harmine that show synergistic activity in vitro [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(9): 666-674.

[12]

Yingjie Hu, Jingying Zhang, Lei Liu, Yan Yan, Limin Mu, Jing Bai, Jiashuan Wu, Wanliang Lu. A novel type of functional epirubicin liposomes modified with DSPE-PEG2000-cyclopamine conjugate for eliminating heterogeneous breast cancer cells [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(4): 255-264.

[13]

Wei Ren, Shuang Zhang, Ting Zhong, Dan Huang, Xin Yao, Yang Guo, Xiaochuan Duan, Yifan Yin, Shushi Zhang, Xuan Zhang. The preparation and characteristics of sterically stabilized liposomes containing paclitaxel and super-paramagnetic iron oxide nanoparticles [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(8): 570-575.

[14]

Hongjun Xie, Lei Liu, Fan Zeng, Limin Mu, Yao Zhao, Yan Yan, Yingjie Hu, Jiashuan Wu, Yingzi Bu, Jingying Zhang, Wanliang Lu. Efficacy and mechanism of antiresistant vinorelbine liposomes in treating resistant breast cancer cells [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(7): 489-501.

[15]

Limin Mu, Jiashuan Wu, Hongjun Xie, Lei Liu, Fan Zeng, Yan Yan, Yao Zhao, Yingjie Hu, Yingzi Bu, Wanliang Lu. The use of a new functional glucose conjugate material, TPGS1000-Glu, in treatment of brain glioma by incorporating into epirubicin liposomes [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(4): 266-274.

PDF (PC)